Join Fund Library now and get free access to personalized features to help you manage your investments.
Alternative Equity Focus
Click for more information on Fundata’s FundGrade
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
|
NAVPS (12-20-2024) |
$17.01 |
|---|---|
| Change |
-$0.35
(-2.04%)
|
As at November 30, 2024
As at November 30, 2024
As at July 31, 2024
Loading...
Inception Return (April 14, 2021): 19.73%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -4.19% | -6.39% | 5.81% | 44.61% | 56.19% | 33.59% | 23.78% | - | - | - | - | - | - | - |
| Benchmark | 6.37% | 10.66% | 16.91% | 25.77% | 30.69% | 15.61% | 10.90% | 13.91% | 11.92% | 12.54% | 10.25% | 10.17% | 10.75% | 8.96% |
| Category Average | 2.82% | 5.16% | 8.23% | 18.68% | 23.73% | 10.56% | 6.75% | 9.47% | 8.00% | - | - | - | - | - |
| Category Rank | 214 / 228 | 199 / 215 | 143 / 205 | 6 / 174 | 6 / 174 | 6 / 149 | 2 / 127 | - | - | - | - | - | - | - |
| Quartile Ranking | 4 | 4 | 3 | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - |
| Return % | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 8.01% | 4.09% | 9.72% | 0.40% | 4.16% | 14.43% | -1.46% | 10.88% | 3.45% | 3.34% | -5.45% | -4.19% |
| Benchmark | 3.91% | 0.55% | 1.82% | 4.14% | -1.82% | 2.77% | -1.42% | 5.87% | 1.22% | 3.15% | 0.85% | 6.37% |
14.43% (May 2024)
-5.62% (December 2022)
| Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | - | - | -1.20% | 30.77% |
| Benchmark | 10.55% | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% |
| Category Average | - | - | - | - | - | - | 5.11% | 17.27% | -5.96% | 6.54% |
| Quartile Ranking | - | - | - | - | - | - | - | - | 2 | 1 |
| Category Rank | - | - | - | - | - | - | - | - | 36/ 127 | 16/ 154 |
30.77% (2023)
-1.20% (2022)
| Name | Percent |
|---|---|
| International Equity | 45.84 |
| US Equity | 38.40 |
| Cash and Equivalents | 13.87 |
| Foreign Government Bonds | 1.90 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| Healthcare | 77.55 |
| Cash and Cash Equivalent | 13.87 |
| Fixed Income | 1.90 |
| Technology | 0.99 |
| Other | 5.69 |
| Name | Percent |
|---|---|
| North America | 54.17 |
| Asia | 40.82 |
| Europe | 5.02 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| Clarity Pharmaceuticals Ltd | 18.29 |
| Telix Pharmaceuticals Ltd | 16.89 |
| SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) | 13.07 |
| Lantheus Holdings Inc | 10.14 |
| Perspective Therapeutics Inc | 5.70 |
| Beigene Ltd - ADR | 5.64 |
| Iovance Biotherapeutics Inc | 4.48 |
| Danaher Corp | 4.19 |
| Amgen Inc | 3.73 |
| Icon PLC | 3.68 |
Portland Life Sciences Alternative Fund Series A
Median
Other - Alternative Equity Focus
| Standard Deviation | 18.84% | - | - |
|---|---|---|---|
| Beta | 0.67% | - | - |
| Alpha | 0.16% | - | - |
| Rsquared | 0.24% | - | - |
| Sharpe | 1.04% | - | - |
| Sortino | 2.51% | - | - |
| Treynor | 0.29% | - | - |
| Tax Efficiency | - | - | - |
| Volatility |
|
- | - |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 21.02% | 18.84% | - | - |
| Beta | 0.36% | 0.67% | - | - |
| Alpha | 0.38% | 0.16% | - | - |
| Rsquared | 0.02% | 0.24% | - | - |
| Sharpe | 2.04% | 1.04% | - | - |
| Sortino | 5.97% | 2.51% | - | - |
| Treynor | 1.20% | 0.29% | - | - |
| Tax Efficiency | 100.00% | - | - | - |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | April 14, 2021 |
|---|---|
| Instrument Type | Mutual Fund (Alternative) |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $16 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| PTL320 | ||
| PTL325 | ||
| PTL330 |
The Fund’s objective is to provide positive long-term total returns by investing primarily in a portfolio of securities focused on companies active in the healthcare sector. The Fund may also engage in borrowing for investment purposes. The Fund’s aggregate exposure shall not exceed limits on the use of gross exposure or as otherwise permitted under applicable securities legislation.
The Fund seeks to provide capital growth by primarily investing in a portfolio of equities, ADRs and may also invest in ETFs. The Fund’s investments currently focus on the area of precision oncology. The Fund also may invest in income trusts, debt securities convertible into common stock, convertible and non-convertible preferred stock, debt-like securities and fixed/floating income securities of governments, government agencies, supranational agencies, companies, trusts and limited partnerships
| Name | Start Date |
|---|---|
| Michael Lee-Chin | 04-13-2021 |
| Dragos Berbecel | 04-14-2021 |
| Fund Manager | Portland Investment Counsel Inc. |
|---|---|
| Advisor | Portland Investment Counsel Inc. |
| Custodian | CIBC Mellon Trust Company |
| Registrar | CIBC Mellon Global Securities Services Company |
| Distributor | Mandeville Private Client Inc. |
| Auditor | KPMG LLP |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 50 |
| PAC Subsequent | 50 |
| SWP Allowed | Yes |
| SWP Min Balance | 5,000 |
| SWP Min Withdrawal | 50 |
| MER | 8.67% |
|---|---|
| Management Fee | 1.75% |
| Load | Choice of Front or No Load |
| FE Max | 6.00% |
| DSC Max | - |
| Trailer Fee Max (FE) | 1.00% |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Join Fund Library now and get free access to personalized features to help you manage your investments.
Fund Library
